RESEARCH - Umbilical cord mesenchymal stem cell transplant shows promise in SLE

[Guest guest]

Umbilical Cord Mesenchymal Stem Cell Transplant Shows Promise for SLE

Medscape

By Will Boggs, MD

NEW YORK (Reuters Health) May 27 - Umbilical cord mesenchymal stem

cell transplantation (UC-MSCT) can improve symptoms and biochemical

values in patients with severe refractory systemic lupus erythematosus

(SLE), a small study from China has shown.

" Since 2007, we have been treating severe and refractory SLE patients "

with this procedure, lead author Dr. Lingyun Sun from The Affiliated

Drum Tower Hospital of Nanjing University Medical School told Reuters

Health by e-mail.

" The disease activity among patients was significantly improved during

the first 3 months of follow-up, " Dr. Sun said. After nearly two

years, " most patients show clinical remission with no adverse events

detected to date or treatment-related mortality. "

**************************************

Read the rest of the article here:

http://www.medscape.com/viewarticle/722598

Not an MD

[Guest guest]

, this is amazing. I will send it to my friend with lupus. What an exciting

research direction. I've been pondering whether to bank the cord blood from this

baby. It's so hard to find unbiased info bc the companies' literature seems to

prey on parents' worst fears. However I wonder if we should do it. Kate F

Sent from my iPhone

On Jun 4, 2010, at 11:50 AM,

<Rheumatoid.Arthritis.Support@...> wrote:

Umbilical Cord Mesenchymal Stem Cell Transplant Shows Promise for SLE

Medscape

By Will Boggs, MD

NEW YORK (Reuters Health) May 27 - Umbilical cord mesenchymal stem

cell transplantation (UC-MSCT) can improve symptoms and biochemical

values in patients with severe refractory systemic lupus erythematosus

(SLE), a small study from China has shown.

" Since 2007, we have been treating severe and refractory SLE patients "

with this procedure, lead author Dr. Lingyun Sun from The Affiliated

Drum Tower Hospital of Nanjing University Medical School told Reuters

Health by e-mail.

" The disease activity among patients was significantly improved during

the first 3 months of follow-up, " Dr. Sun said. After nearly two

years, " most patients show clinical remission with no adverse events

detected to date or treatment-related mortality. "

**************************************

Read the rest of the article here:

http://www.medscape.com/viewarticle/722598

Not an MD

[Guest guest]

I have decided that I as a grandparent (I have none yet) will pay to have

all my grandchildren's cord blood banked. I figure it's the least I can do

since the autoimmune is from my side of the family.

Just my 2 cents.

in PA

On Fri, Jun 4, 2010 at 1:14 PM, Kate Fair <kalfoley@...> wrote:

>

>

> , this is amazing. I will send it to my friend with lupus. What an

> exciting research direction. I've been pondering whether to bank the cord

> blood from this baby. It's so hard to find unbiased info bc the companies'

> literature seems to prey on parents' worst fears. However I wonder if we

> should do it. Kate F

>

> Sent from my iPhone

>

> On Jun 4, 2010, at 11:50 AM, <

>

Rheumatoid.Arthritis.Support@...<Rheumatoid.Arthritis.Support%40gmail.com>\

>

> wrote:

>

> Umbilical Cord Mesenchymal Stem Cell Transplant Shows Promise for SLE

>

> Medscape

> By Will Boggs, MD

>

> NEW YORK (Reuters Health) May 27 - Umbilical cord mesenchymal stem

> cell transplantation (UC-MSCT) can improve symptoms and biochemical

> values in patients with severe refractory systemic lupus erythematosus

> (SLE), a small study from China has shown.

>

> " Since 2007, we have been treating severe and refractory SLE patients "

> with this procedure, lead author Dr. Lingyun Sun from The Affiliated

> Drum Tower Hospital of Nanjing University Medical School told Reuters

> Health by e-mail.

>

> " The disease activity among patients was significantly improved during

> the first 3 months of follow-up, " Dr. Sun said. After nearly two

> years, " most patients show clinical remission with no adverse events

> detected to date or treatment-related mortality. "

>

> **************************************

> Read the rest of the article here:

>

> http://www.medscape.com/viewarticle/722598

>

>

> Not an MD

>

>

[Guest guest]

can I put you in touch with my father?

Kate F

Sent from my iPhone

On Jun 4, 2010, at 12:18 PM, McNally <mhm423@...> wrote:

I have decided that I as a grandparent (I have none yet) will pay to have

all my grandchildren's cord blood banked. I figure it's the least I can do

since the autoimmune is from my side of the family.

Just my 2 cents.

in PA

On Fri, Jun 4, 2010 at 1:14 PM, Kate Fair <kalfoley@...> wrote:

, this is amazing. I will send it to my friend with lupus. What an

exciting research direction. I've been pondering whether to bank the cord

blood from this baby. It's so hard to find unbiased info bc the companies'

literature seems to prey on parents' worst fears. However I wonder if we

should do it. Kate F

Sent from my iPhone

On Jun 4, 2010, at 11:50 AM, <

Rheumatoid.Arthritis.Support@...<Rheumatoid.Arthritis.Support%40gmail.com>\

>

wrote:

Umbilical Cord Mesenchymal Stem Cell Transplant Shows Promise for SLE

Medscape

By Will Boggs, MD

NEW YORK (Reuters Health) May 27 - Umbilical cord mesenchymal stem

cell transplantation (UC-MSCT) can improve symptoms and biochemical

values in patients with severe refractory systemic lupus erythematosus

(SLE), a small study from China has shown.

" Since 2007, we have been treating severe and refractory SLE patients "

with this procedure, lead author Dr. Lingyun Sun from The Affiliated

Drum Tower Hospital of Nanjing University Medical School told Reuters

Health by e-mail.

" The disease activity among patients was significantly improved during

the first 3 months of follow-up, " Dr. Sun said. After nearly two

years, " most patients show clinical remission with no adverse events

detected to date or treatment-related mortality. "

**************************************

Read the rest of the article here:

http://www.medscape.com/viewarticle/722598

Not an MD